Acies Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Dehradun, Uttarakhand, India, established in 2019.
2019 Dehradun, Uttarakhand, India Active
Last Updated:
Access Report
About Acies Pharmaceutical Private Limited

Acies Pharmaceutical Private Limited, a active private limited company, was established on 19 April 2019 in Dehradun, Uttarakhand, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999UR2019PTC009735. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Bhasker Dabral (Director), Sujata Dabral (Director). It holds ₹10.39 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at First Floor 74/1 Nari Shilip Marg, Dehradun, Uttarakhand, 248001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999UR2019PTC009735

  • Registration Number

    009735

  • Incorporation Date

    19 April 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Uttarakhand

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 10.39 Cr
  • Revenue Growth **** 30.63%
  • Profit Growth **** 106.90%
  • Ebitda **** 42.51%
  • Net Worth 90.89%
  • Total Assets **** 36.29%
Company report

Acies Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Acies Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Acies Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhasker Dabral Director 19 Apr 2019 Current
Sujata Dabral Director 19 Apr 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Acies Pharmaceutical.

Acies Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.63% increase. The company also saw a substantial improvement in profitability, with a 106.9% increase in profit. The company's net worth Soared by an impressive increase of 90.89%.

Acies Pharmaceutical revenue growth over time
Acies Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 30.63%
*******
*******
*******
*******
Revenue from Operations
*******
 29.80%
*******
*******
*******
*******
Total Assets
*******
 36.29%
*******
*******
*******
*******
Profit or Loss
*******
 106.90%
*******
*******
*******
*******
Net Worth
*******
 90.89%
*******
*******
*******
*******
EBITDA
*******
 42.51%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Acies Pharmaceutical?

Unlock access to Acies Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹103,900,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 6.79 Cr
  • Axis Bank Limited : 3.60 Cr
Latest Charge Details
Date Lender Amount Status
27 May 2025 Others ₹5.39 Cr Open
24 Jan 2024 Axis Bank Limited ₹3.60 Cr Open
29 Jan 2022 Others ₹1.40 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Acies Pharmaceutical?

Unlock and access historical data on people associated with Acies Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Acies Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acies Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Acies Pharmaceutical
Recent Activity within the Organization
  • Annual General Meeting

    Acies Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 53.90 M with Charge ID 101100014 was registered on 27 May 2025. was completed.

  • Balance Sheet

    The activity Acies Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand. was completed.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 36.00 M with Charge ID 100880730 was registered on 24 Jan 2024. was completed.

  • Charges

    The activity A charge with Others of Rs. 14.00 M registered on 29 Jan 2022 with Charge ID 100540219 was modified on 25 May 2023. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 14.00 M with Charge ID 100540219 was registered on 29 Jan 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Acies Pharmaceutical Private Limited?

The CIN of Acies Pharmaceutical Private Limited is U74999UR2019PTC009735.

Where is Acies Pharmaceutical Private Limited headquartered?

Acies Pharmaceutical Private Limited is headquartered at First Floor 74/1 Nari Shilip Marg, Dehradun, Uttarakhand, 248001.

When was Acies Pharmaceutical Private Limited incorporated?

Acies Pharmaceutical Private Limited was incorporated on 19 April 2019.

Who are the current directors of Acies Pharmaceutical Private Limited?

The current directors of Acies Pharmaceutical Private Limited are

What is the primary industry of Acies Pharmaceutical Private Limited?

The primary industry of Acies Pharmaceutical Private Limited is Trade.

Is Acies Pharmaceutical Private Limited a listed company?

Acies Pharmaceutical Private Limited is unlisted.

What is the capital structure of Acies Pharmaceutical Private Limited?

The authorized capital of Acies Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available